Market Place
Sourcing Support
All News #Library
Biotech
Revolution, Ascendis Seen As Top Buyout Targets In Biopharma
19 Mar 2026 //
BIOSPACE
Biocryst To Unveil ORLADEYO And Navenibart Data At AAAAI 2026
11 Feb 2026 //
GLOBENEWSWIRE
BioCryst Complete Acquisition Astria to Lead HAE Treatment
23 Jan 2026 //
GLOBENEWSWIRE
Astria Stockholders Vote To Approve Acquisition By BioCryst
21 Jan 2026 //
BUSINESSWIRE
Biocryst To Unveil Pediatric HAE Data At ACAAI 2025 Meeting
23 Oct 2025 //
GLOBENEWSWIRE
Biocryst Reports Inducement Grants Per Nasdaq LR 5635(C)(4)
03 Oct 2025 //
GLOBENEWSWIRE
BioCryst to Present at Upcoming Investor Conferences
27 May 2025 //
GLOBENEWSWIRE
BioCryst to Report First Quarter 2025 Financial Results on May 5
21 Apr 2025 //
GLOBENEWSWIRE
BioCryst Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
06 Jan 2025 //
GLOBENEWSWIRE
BioCryst to Present at Upcoming Investor Conferences
06 Nov 2024 //
GLOBENEWSWIRE
BioCryst Presents Real-World Evidence For ORLADEYO®
24 Oct 2024 //
GLOBENEWSWIRE
BioCryst Presents New Orladeyo Data At Bradykinin Symposium
06 Sep 2024 //
GLOBENEWSWIRE
BioCryst Appoints Dr. Donald Fong Chief Medical Officer
05 Sep 2024 //
GLOBENEWSWIRE
BioCryst Reports Inducement Grants Under Nasdaq Listing
04 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.